ClinicalTrials.Veeva

Menu
Yuma Clinical Trials | Yuma, AZ logo

Yuma Clinical Trials | Yuma, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SCD-044
Tirzepatide
Bimagrumab
Vicadrostat
BI 690517
Survodutide
X0002
Ixekizumab
Orforglipron
CT-388

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Overweight or Obese
Drug: CT-388
Drug: Placebo

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the pre...

Active, not recruiting
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab

This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.

Active, not recruiting
Moderate to Severe Plaque Psoriasis
Drug: Placebo
Drug: SCD-044_Dose 3

Trial sponsors

Lilly logo
Boehringer Ingelheim logo
Sun Pharma logo
C
Sanofi logo
Techfields logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems